Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma

doi:10.3748/wjg.v16.i24.3025

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 24

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3750)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-5) series.

Item

Count

PDF

316

HTML

3330

Tables (1-5)

104

Sum=3750

Jun 28, 2010 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (52)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jun 28, 2010; 16(24): 3025-3032
Published online Jun 28, 2010. doi: 10.3748/wjg.v16.i24.3025

Table 1 Mean prevalence of HCV infection, HBV infection, alcohol abuse and DM2 in the free living population of the Pordenone area and controls in this study

	General population (%)		Control group of the study (%)
	Global	60-75 yr age interval	Control group of the study (%)
HCV positive	3.2	5.0	5.3
HBV positive	1.2	1.7	1.2
Alcohol abuse	4.5	5.0	4.7
DM2	4.8	12.4	12.6

HCV: Hepatitis C virus; HBV: Hepatitis B virus; DM2: Type 2 diabetes mellitus.

Citation: Donadon V, Balbi M, Valent F, Avogaro A. Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma. World J Gastroenterol 2010; 16(24): 3025-3032
URL: https://www.wjgnet.com/1007-9327/full/v16/i24/3025.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i24.3025